Schizophrenia trials recruiting in Nevada

All Schizophrenia trials nationally

Cities in Nevada

Recruiting trials in Nevada

• 52-week Open Label Safety-Tolerability Study
  NCT07369154 · Phase: Phase 3 · Ages: 18 Years to 65 Years · Sex: All (male and female) · Nevada: Las Vegas
• A Long-Term Open-Label Study of ML-007C-MA in Adults With Schizophrenia
  NCT07459647 · Phase: Phase 2 · Ages: 18 Years to 65 Years · Sex: All (male and female) · Nevada: Las Vegas
• A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis
  NCT06887192 · Phase: Phase 2 · Ages: 55 Years to 90 Years · Sex: All (male and female) · Nevada: Las Vegas
• A Study to Evaluate the Effect of KarXT on Urological Safety
  NCT07221877 · Phase: Phase 4 · Ages: 18 Years to 65 Years · Sex: All (male and female) · Nevada: Las Vegas
• A Study to Evaluate the Long-term Safety and Tolerability of KarXT and KarX-EC for the Treatment of Schizophrenia and Autism-Related Irritability in Adolescents, Respectively
  NCT07424404 · Phase: Phase 3 · Ages: 5 Years to 17 Years · Sex: All (male and female) · Nevada: Las Vegas
• Effectiveness and Adverse-effect Switch Evaluation of Xanomeline and Trospium Chloride (KarXT)
  NCT07379827 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · Nevada: Las Vegas
• Randomized Withdrawal Study in Patients With Schizophrenia
  NCT06961968 · Phase: Phase 3 · Ages: 18 Years to 65 Years · Sex: All (male and female) · Nevada: Las Vegas
• Safety and Tolerability Trial of Lumateperone in Pediatric Patients With Schizophrenia, Bipolar Disorder or Autism Spectrum Disorder
  NCT06229210 · Phase: Phase 3 · Ages: 5 Years to 17 Years · Sex: All (male and female) · Nevada: Las Vegas